Australian Clinical Labs (ACL) is an Australian private provider of pathology services. The Company's NATA accredited laboratories perform a diverse range of pathology tests each year for a range of clients including doctors, specialists, patients, hospitals and corporate clients.
Find out what a historical investment in Australian Clinical Labs Limited would be worth today using our ACL stock calculator.
Buying ACL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Australian Clinical Labs Limited in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in ACL
What is the ticker symbol of Australian Clinical Labs Limited?
The ticker symbol for Australian Clinical Labs Limited is ACL.
How much is one share of ACL?
One share of ACL is valued at $3.32 as of 22 November 2026.
What is the market capitalisation of Australian Clinical Labs Limited ACL?
As of 22 November 2026 Australian Clinical Labs Limited has a market cap of $624.84M.
Does ACL pay dividends?
Yes, ACL does pay dividends.
What is the dividend yield for ACL?
The dividend yield for ACL is 3.90% as of 22 November 2026.
How much dividends does ACL pay?
The most recent ACL dividend distribution paid $0.09 per share on 23 September 2026.
What is the ACL ex-dividend date?
The ex-dividend date of ACL was 02 September 2026.
What is the P/E ratio of ACL?
The Price to Earnings ratio of ACL is 27.17.
What is the Earnings Per Share of ACL?
The Earnings Per Share of ACL is $0.12.
What is the 52-week high for Australian Clinical Labs Limited stock?
The Australian Clinical Labs Limited 52-week high stock price is $3.39.
What is the 52-week low for Australian Clinical Labs Limited stock?
The Australian Clinical Labs Limited 52-week low stock price is $1.83.
Can I buy ACL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ACL shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.